Topics:
Melanoma/Skin Cancer • Medical Oncology • Renal Cell Carcinoma • Thrombosis • Hematology • Benign Hematology • Hemostasis/Thrombosis
How do you approach anticoagulation in patients with hypervascular tumors at high risk for bleeding, e.g. melanoma, RCC, choriocarcinoma with brain metastasis?
- How would management change based off treatment indication: (1) PICC-associated SVT with high Khorana score in a patient who needs a central access for treatment (2) DVT